Search for: "BRISTOL-MYERS SQUIBB" Results 401 - 420 of 863
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Dec 2006, 4:41 am
The revised guidelines follow criticism that the tactics used in recent years against companies like the drug maker Bristol-Myers Squibb and the accounting firm KPMG were coercive and unconstitutional. they are being made at a time when companies are seeking — and receiving — greater protection from criminal and regulatory scrutiny. [read post]
21 Jul 2011, 1:17 pm
The drug is being developed by Bristol-Myers Squibb and AstraZeneca, and other major manufacturers such as Johnson & Johnson and Eli Lilly are pursing similar drugs. [read post]
24 Jan 2012, 11:12 am by Ray Mullman
Use of antipsychotics such as J&J's Risperdal and Bristol-Myers Squibb Co.'s Abilify grew substantially in the past decade in both kids and adults. [read post]
17 Sep 2018, 2:59 am by Walter Olson
ArsTechnica] “Prosecutors Are Said to Issue Subpoenas Over Pelvic-Mesh Surgery Financing” [Matthew Goldstein and Jessica Silver-Greenberg, New York Times, earlier and more] Federal courts split on whether SCOTUS’s Bristol-Myers Squibb limits on personal jurisdiction apply to class actions [Bradley Arent, Akin Gump, Carlton Fields] Tags: arbitration, class actions, deep pocket, litigation finance, opioids, Texas [read post]
28 Jul 2009, 1:11 pm
Some of the lawyers come from impressive backgrounds, including a former senior patent attorney at Bristol-Myers Squibb and a venture capitalist who worked at GE Asset Management. [read post]
31 May 2008, 2:44 pm
- Seattle attorney Ken Odza of Stoel Rives in the firm's Food Liability Law Blog Bristol-Myers Squibb to acquire Kosan Biosciences for $190 million - Los Gatos lawyer Kristie Prinz in her California Biotech Law Blog New jails are not the answer - Waco attorney Walter Reaves in his Texas Criminal Law Blog Mad cow Korea: social amplification of risk, Internet style - Kansas State University professor Doug Powell in the International Food Safety Network's… [read post]
11 Feb 2011, 1:30 pm by Lucas A. Ferrara, Esq.
Batts United States District Judge, Southern District of New York Sandra Leung General Counsel and Corporate Secretary, Bristol-Myers Squibb Michele Coleman Mayes Senior Vice President and General Counsel, Allstate Insurance Company Hon. [read post]
28 Jan 2010, 7:19 am by Brian Hollar
A reminder that correlation does not imply causality: Derek Lowe of Corante’s ‘In the Pipeline’ (a drug-discovery blog) points to this graph in an article by Bristol-Myers Squibb’s Stephen Johnson, titled, The Trouble with QSAR (OR How I Stopped Worrying and Embrace Fallacy). [read post]
2 Sep 2016, 11:45 am by Clay Hodges
The defendant, Bristol-Myers Squibb, sought the dismissal of the claims by the 592 non-Californian plaintiffs. [read post]
19 Jun 2017, 1:33 pm by Andrew Hamm
.: Ronald Mann analyzed the court’s opinion in Bristol-Myers Squibb Co. v. [read post]
2 Sep 2016, 11:45 am by Clay Hodges
The defendant, Bristol-Myers Squibb, sought the dismissal of the claims by the 592 non-Californian plaintiffs. [read post]
22 Feb 2021, 12:25 pm by Sabrina I. Pacifici
Among the blue-chip firms that participated in the 2021 survey were American Express, Anthem, Bank of America, Bristol-Myer Squibb, Capital One, Cigna, CVS Health, Eli Lilly, Glaxo Smith Kline, JP Morgan Chase, Liberty Mutual, Mastercard, McDonalds, Merck, Pfizer, Sanofi, Starbucks, United Health, VISA, and Walmart. [read post]
19 Jul 2015, 5:09 pm by Sabrina I. Pacifici
Bristol-Myers Squibb, No. 26, is selling an immunotherapy drug that is saving the lives of people with skin and lung cancer…” Nanette Byrnes [read post]
26 Jun 2015, 11:30 am
  Our readers already know that it took the California Supreme Court less than four months to depublish Bristol-Myers Squibb (reported here). [read post]
29 Feb 2012, 7:24 am
Squibbs and Sons (now known as Bristol-Myers Squibb) and many other companies including 70 other similar types of synthetic hormones . [read post]
9 Aug 2006, 9:46 am
This is the latest development in a legal morass that has developed between Apotex and the brand name drug co-marketers, Sanofi-Aventis SA and Bristol-Myers Squibb Co., after their deal that would have delayed bringing a generic to market for another five years was blocked. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/28: Bristol-Myers Squibb Co., Bristol-Myers Squibb Pharma Co. v. [read post]